NIDEK Receives FDA Marketing Clearance for NIDEK MC-300

NIDEK, a U.S. leader in advanced ophthalmic laser technologies, announced that it received FDA marketing clearance for commercial release of its new MC-300 Multicolor Laser Photocoagulator System. The new laser will continue to establish NIDEK as a comprehensive laser provider for the fast-growing retinal laser market. The MC-300 laser system has been commercially available in international markets and has received outstanding reviews and clinical results from retinal specialists in Asia and Europe.

PrimeZone (http://www.primezone.com/newsroom/?d=76215)